• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌中静脉血栓的预后意义。肾静脉和下腔静脉受累情况是否不同?

Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

作者信息

Kim Hyung L, Zisman Amnon, Han Ken-Ryu, Figlin Robert A, Belldegrun Arie S

机构信息

Department of Urology, University of California School of Medicine, Los Angeles, 90095, USA.

出版信息

J Urol. 2004 Feb;171(2 Pt 1):588-91. doi: 10.1097/01.ju.0000104672.37029.4b.

DOI:10.1097/01.ju.0000104672.37029.4b
PMID:14713765
Abstract

PURPOSE

The prognostic significance of the level of venous involvement in renal cell carcinoma (RCC) is controversial. It has been suggested that the 1997 TNM classification of venous involvement system should be revised.

MATERIALS AND METHODS

The records of 226 patients who underwent a nephrectomy and tumor thrombectomy, 117 for renal vein (RV) and 109 for inferior vena cava (IVC) involvement, between 1989 and 2001 were reviewed and compared to those of 654 patients undergoing nephrectomy without venous involvement.

RESULTS

In patients with localized RCC (N0M0), the risk of recurrence after nephrectomy was significantly increased in patients with venous thrombus compared to patients without venous thrombus (p = 0.005). However, the difference was not significant in a multivariate analysis including T stage (1, 2, 3 or 4), Fuhrman grade and Eastern Cooperative Oncology Group performance status. In patients with localized RCC disease specific survival was similar (p = 0.536) in patients with RV (T3b) and IVC involvement below the diaphragm (T3b). However, patients with IVC involvement above the diaphragm (T3c) had a significantly worse survival rate even after controlling for Fuhrman grade and Eastern Cooperative Oncology Group performance status in a multivariate analysis (p = 0.020). All patients treated for metastatic RCC had a similar prognosis regardless of the level of venous involvement.

CONCLUSIONS

For patients with pT3b disease, local tumor stage and grade are better predictors of prognosis than extent of venous involvement. Based on our data we support the current TNM classification of venous involvement with RV and IVC invasion categorized as T3b and IVC involvement above the diaphragm categorized as T3c.

摘要

目的

肾细胞癌(RCC)中静脉受累程度的预后意义存在争议。有人建议应修订1997年静脉受累的TNM分类系统。

材料与方法

回顾了1989年至2001年间226例行肾切除术和肿瘤血栓切除术患者的记录,其中117例为肾静脉(RV)受累,109例为下腔静脉(IVC)受累,并与654例未发生静脉受累而行肾切除术的患者记录进行比较。

结果

在局限性RCC(N0M0)患者中,与无静脉血栓的患者相比,有静脉血栓的患者肾切除术后复发风险显著增加(p = 0.005)。然而,在包括T分期(1、2、3或4)、Fuhrman分级和东部肿瘤协作组体能状态的多因素分析中,差异不显著。在局限性RCC患者中,RV(T3b)受累和膈肌以下IVC受累(T3b)患者的疾病特异性生存率相似(p = 0.536)。然而,即使在多因素分析中控制了Fuhrman分级和东部肿瘤协作组体能状态后,膈肌以上IVC受累(T3c)的患者生存率仍显著较差(p = 0.020)。所有接受转移性RCC治疗的患者,无论静脉受累程度如何,预后相似。

结论

对于pT3b期疾病患者,局部肿瘤分期和分级比静脉受累程度更能预测预后。基于我们的数据,我们支持目前将RV和IVC侵犯的静脉受累TNM分类为T3b,膈肌以上IVC受累分类为T3c。

相似文献

1
Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?肾细胞癌中静脉血栓的预后意义。肾静脉和下腔静脉受累情况是否不同?
J Urol. 2004 Feb;171(2 Pt 1):588-91. doi: 10.1097/01.ju.0000104672.37029.4b.
2
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
3
Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.术前转移状态、血栓水平和体重指数可预测接受肾切除术和下腔静脉血栓切除术的患者的总生存率。
BJU Int. 2012 Dec;110(11 Pt B):E470-4. doi: 10.1111/j.1464-410X.2012.11155.x. Epub 2012 Apr 23.
4
Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.伴有肿瘤血栓延伸的肾细胞癌:生物学特性、肾切除术的作用及对免疫治疗的反应
J Urol. 2003 Mar;169(3):909-16. doi: 10.1097/01.ju.0000045706.35470.1e.
5
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.细胞减灭性肾切除术治疗伴有静脉瘤栓的肾细胞癌。
J Urol. 2017 Aug;198(2):281-288. doi: 10.1016/j.juro.2017.03.011. Epub 2017 Mar 6.
6
Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.韩国肾细胞癌伴静脉瘤栓患者的预后因素:新 2009 年 TNM 分期系统的应用。
Int Braz J Urol. 2013 May-Jun;39(3):353-63. doi: 10.1590/S1677-5538.IBJU.2013.03.08.
7
Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.肾细胞癌侵犯下腔静脉患者手术治疗的临床结局
Int J Urol. 2007 Sep;14(9):781-4. doi: 10.1111/j.1442-2042.2007.01749.x.
8
[Prognostic value of venous tumor thrombus in renal cell carcinoma].[肾细胞癌中静脉瘤栓的预后价值]
Actas Urol Esp. 2012 Jan;36(1):29-34. doi: 10.1016/j.acuro.2011.06.002. Epub 2011 Jul 30.
9
Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.手术对接受 TKI 治疗的伴有 IVC 血栓的转移性肾细胞癌预后的影响。
J Surg Oncol. 2014 Aug;110(2):145-50. doi: 10.1002/jso.23612. Epub 2014 Apr 3.
10
Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.接受手术治疗的伴有血管肿瘤血栓的肾细胞癌患者的预后风险分层及临床结局
Urology. 2007 Jun;69(6):1054-8. doi: 10.1016/j.urology.2007.02.052.

引用本文的文献

1
Two-Stage Tumor Resection for Locally Advanced Renal Cell Carcinoma With Level IV Tumor Thrombus and Pulmonary Embolism: A Case Report.两阶段肿瘤切除术治疗伴有IV级肿瘤血栓和肺栓塞的局部晚期肾细胞癌:病例报告
IJU Case Rep. 2025 Jun 16;8(4):382-385. doi: 10.1002/iju5.70045. eCollection 2025 Jul.
2
Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128).免疫检查点抑制剂在肾细胞癌静脉瘤栓缩小中的疗效(UroCCR 128)
World J Urol. 2025 Jan 10;43(1):66. doi: 10.1007/s00345-024-05428-w.
3
Late Survival and Long-Term Follow-Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus.
晚期肾细胞癌合并静脉瘤栓根治性切除术后的远期生存及长期随访
J Surg Oncol. 2025 Apr;131(5):917-924. doi: 10.1002/jso.28020. Epub 2024 Nov 26.
4
Bibliometric analysis of renal cell carcinoma with venous tumor thrombus.肾细胞癌伴静脉瘤栓的文献计量学分析。
Int J Med Sci. 2024 Aug 12;21(11):2094-2108. doi: 10.7150/ijms.98359. eCollection 2024.
5
Circumferential Inferior Vena Cavectomy Without Caval Replacement in the Management of Renal Cell Carcinoma with Tumor Thrombus.肾细胞癌合并肿瘤血栓的治疗中不进行腔静脉置换的周径下腔静脉切除术。
Curr Urol Rep. 2024 Jun;25(6):117-124. doi: 10.1007/s11934-024-01203-x. Epub 2024 May 20.
6
Scientific Status Quo of Small Renal Lesions: Diagnostic Assessment and Radiomics.小肾病变的科学现状:诊断评估与放射组学
J Clin Med. 2024 Jan 18;13(2):547. doi: 10.3390/jcm13020547.
7
Validity of a multiphase CT-based radiomics model in predicting the Leibovich risk groups for localized clear cell renal cell carcinoma: an exploratory study.基于多期CT的影像组学模型预测局限性透明细胞肾细胞癌Leibovich风险组的有效性:一项探索性研究。
Insights Imaging. 2023 Oct 10;14(1):167. doi: 10.1186/s13244-023-01526-2.
8
Technical Tips for Performing Suprahepatic Vena Cava Tumor Thrombectomy in Renal Cell Carcinoma without Using Cardiopulmonary Bypass.在不使用体外循环的情况下对肾细胞癌进行肝上腔静脉肿瘤血栓切除术的技术要点
Vasc Specialist Int. 2023 Sep 4;39:23. doi: 10.5758/vsi.230056.
9
Diagnostic performance and prognostic value of preoperative F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus.术前 F-FDG PET/CT 对伴有静脉瘤栓的肾细胞癌患者的诊断性能和预后价值。
Cancer Imaging. 2022 Nov 26;22(1):65. doi: 10.1186/s40644-022-00502-1.
10
The Significant Role of Tumor Volume on the Surgical Approach Choice, Surgical Complexity, and Postoperative Complications in Renal Cell Carcinoma With Venous Tumor Thrombus From a Large Chinese Center Experience.来自中国大型中心的经验:肿瘤体积在伴静脉瘤栓的肾细胞癌手术方式选择、手术复杂性及术后并发症中的重要作用
Front Oncol. 2022 Jun 7;12:869891. doi: 10.3389/fonc.2022.869891. eCollection 2022.